Published in Brain Res on January 22, 2005
Sex, gender, and pain: a review of recent clinical and experimental findings. J Pain (2009) 5.62
Developmental vitamin D deficiency alters dopamine-mediated behaviors and dopamine transporter function in adult female rats. Psychopharmacology (Berl) (2009) 0.96
Behavioral effects of chronic methamphetamine treatment in HIV-1 gp120 transgenic mice. Behav Brain Res (2012) 0.86
Sex differences in striatal dopaminergic function within heterozygous mutant dopamine transporter knock-out mice. J Neural Transm (Vienna) (2008) 0.85
Mesocorticolimbic monoamine correlates of methamphetamine sensitization and motivation. Front Syst Neurosci (2014) 0.84
Obesity at conception programs the opioid system in the offspring brain. Neuropsychopharmacology (2013) 0.82
Prepulse inhibition in HIV-1 gp120 transgenic mice after withdrawal from chronic methamphetamine. Behav Pharmacol (2014) 0.82
Intravenous cocaine self-administration: individual differences in male and female C57BL/6J mice. Pharmacol Biochem Behav (2007) 0.82
Gonadectomy and hormone replacement exert region- and enzyme isoform-specific effects on monoamine oxidase and catechol-O-methyltransferase activity in prefrontal cortex and neostriatum of adult male rats. Neuroscience (2009) 0.81
Reversal of dopamine system dysfunction in response to high-fat diet. Obesity (Silver Spring) (2013) 0.80
In vitro binding assays using (3)H nisoxetine and (3)H WIN 35,428 reveal selective effects of gonadectomy and hormone replacement in adult male rats on norepinephrine but not dopamine transporter sites in the cerebral cortex. Neuroscience (2008) 0.77
Male/Female differences in neuroprotection and neuromodulation of brain dopamine. Front Endocrinol (Lausanne) (2011) 0.76
Markers associated with sex differences in methamphetamine-induced striatal dopamine neurotoxicity. Curr Neuropharmacol (2011) 0.76
Sex differences in the acute locomotor response to methamphetamine in BALB/c mice. Behav Brain Res (2017) 0.75
Gender differences in Parkinson's disease. J Neurol Neurosurg Psychiatry (2006) 2.23
Neuroprotective actions of sex steroids in Parkinson's disease. Front Neuroendocrinol (2009) 1.37
Estrogen prevents neuroprotection by caffeine in the mouse 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson's disease. J Neurosci (2006) 1.03
Protective effects of ginsenoside Rg2 against glutamate-induced neurotoxicity in PC12 cells. J Ethnopharmacol (2006) 1.01
Oestrogen and nigrostriatal dopaminergic neurodegeneration: animal models and clinical reports of Parkinson's disease. Clin Exp Pharmacol Physiol (2007) 0.92
Methamphetamine-induced loss of striatal dopamine innervation in BDNF heterozygote mice does not further reduce D3 receptor concentrations. Synapse (2004) 0.88
Sex differences in methamphetamine toxicity in mice: effect on brain dopamine signaling pathways. Psychoneuroendocrinology (2011) 0.87
Sex differences in striatal dopaminergic function within heterozygous mutant dopamine transporter knock-out mice. J Neural Transm (Vienna) (2008) 0.85
Signaling pathways mediating the neuroprotective effects of sex steroids and SERMs in Parkinson's disease. Front Neuroendocrinol (2012) 0.83
Genetic alteration in the dopamine transporter differentially affects male and female nigrostriatal transporter systems. Biochem Pharmacol (2009) 0.82
Structure-activity relationship and docking studies of thiazolidinedione-type compounds with monoamine oxidase B. Bioorg Med Chem Lett (2011) 0.81
Methyl Yellow: A Potential Drug Scaffold for Parkinson's Disease. Chembiochem (2014) 0.81
Nomifensine alters sex differences in striatal dopaminergic function. Synapse (2012) 0.80
Dose-response effects of estrogen and tamoxifen upon methamphetamine-induced behavioral responses and neurotoxicity of the nigrostriatal dopaminergic system in female mice. Neuroendocrinology (2004) 0.80
Testosterone enhances dopamine depletion by methamphetamine in male, but not female, mice. Neurosci Lett (2008) 0.80
Sex and temporally-dependent effects of methamphetamine toxicity on dopamine markers and signaling pathways. Neuropharmacology (2012) 0.79
Testosterone modulation of striatal dopamine output in orchidectomized mice. Synapse (2006) 0.78
Effect of estrogen upon methamphetamine-induced neurotoxicity within the impaired nigrostriatal dopaminergic system. Synapse (2006) 0.78
Differential protective properties of estradiol and tamoxifen against methamphetamine-induced nigrostriatal dopaminergic toxicity in mice. Neuroendocrinology (2006) 0.78
Rotenone produces opposite effects upon mouse striatal dopamine function as a result of environmental temperature. Neurotox Res (2006) 0.77
Dopamine transporter as a marker of neuroprotection in methamphetamine-lesioned mice treated acutely with estradiol. Neuroendocrinology (2004) 0.76
Estrogen and Parkinson's disease. Adv Neurol (2003) 0.76
Markers associated with testosterone enhancement of methamphetamine-induced striatal dopaminergic neurotoxicity. Neurotoxicol Teratol (2012) 0.76
Tamoxifen protects male mice nigrostriatal dopamine against methamphetamine-induced toxicity. Biochem Pharmacol (2007) 0.76
Male/Female differences in neuroprotection and neuromodulation of brain dopamine. Front Endocrinol (Lausanne) (2011) 0.76
Dimebon attenuates methamphetamine, but not MPTP, striatal dopamine depletion. Neurochem Int (2012) 0.76
Sex differences in methamphetamine-evoked striatal dopamine of mice are reversed by nomifensine. Neurotoxicol Teratol (2006) 0.75
Effects of estrogen and related agents upon methamphetamine-induced neurotoxicity within an impaired nigrostriatal dopaminergic system of ovariectomized mice. Neuroendocrinology (2006) 0.75
Tamoxifen increases methamphetamine-evoked dopamine output from superfused striatal tissue fragments of male mice. Brain Res (2004) 0.75
Effects of a novel dopamine uptake inhibitor upon extracellular dopamine from superfused murine striatal tissue. Eur J Pharmacol (2009) 0.75
Castration increases nisoxetine-evoked norepinephrine levels in vivo within the olfactory bulb of male rats. Neurosci Lett (2002) 0.75